Rates of HIV-associated dementia have decreased from approximately 50% in the pre-cART era to 2% currently. However, roughly 50% of patients treated with cART have the milder forms of HIV-associated neurocognitive disorder (HAND).
This article describes the populations at high risk for HIV infection and reports the results of a collaborative, multifaceted educational intervention designed to reduce the documented disparities related to HIV care and prevention.
The International Antiviral Society published updated 2020 recommendations on use of antiretroviral therapy, laboratory monitoring and screening, prevention, and management of older patients living with HIV.
Based on guidelines issued by the World Health Organizations in 2018, the American College of Physicians has issued best practice advice that simplifies and improves treatment of chronic hepatitis C virus.
Study authors investigated patients’ perceptions to utilizing telehealth as an alternative for face-to-face in-person care, hoping to overcome barriers of patient retention such as transportation-related challenges, stigma, and fear of HIV status disclosure.
Study authors assessed various demographic, HIV-specific, and antiretroviral-therapy-specific risk factors associated with weight gain following initiation of antiretroviral therapy in patients with HIV.
A major concern in people with HIV includes accelerated atherosclerosis, underlined by increased rates of coronary artery disease. Researchers investigated the longitudinal progression of atherosclerosis in persons with HIV vs without HIV in the Swiss population.
Researchers assessed the risk of diabetes mellitus, weight gain, and their relationships with integrase inhibitor-based initial antiretroviral therapy among persons with HIV in the United States and Canada.